TW200716101A - 7-fluoro-1, 3-dihydro-indol-2-one oxazolidinones as antibacterial agents - Google Patents

7-fluoro-1, 3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Info

Publication number
TW200716101A
TW200716101A TW095112018A TW95112018A TW200716101A TW 200716101 A TW200716101 A TW 200716101A TW 095112018 A TW095112018 A TW 095112018A TW 95112018 A TW95112018 A TW 95112018A TW 200716101 A TW200716101 A TW 200716101A
Authority
TW
Taiwan
Prior art keywords
antibacterial agents
fluoro
oxazolidinones
indol
dihydro
Prior art date
Application number
TW095112018A
Other languages
English (en)
Chinese (zh)
Inventor
Mikhail Fedor Gordeev
Vara Prasad Venkata Nagendra Josyula
Gary Wayne Luehr
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of TW200716101A publication Critical patent/TW200716101A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095112018A 2005-04-06 2006-04-04 7-fluoro-1, 3-dihydro-indol-2-one oxazolidinones as antibacterial agents TW200716101A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66871505P 2005-04-06 2005-04-06
US68403305P 2005-05-24 2005-05-24

Publications (1)

Publication Number Publication Date
TW200716101A true TW200716101A (en) 2007-05-01

Family

ID=36636389

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095112018A TW200716101A (en) 2005-04-06 2006-04-04 7-fluoro-1, 3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Country Status (21)

Country Link
US (1) US7435751B2 (https=)
EP (1) EP1869030A1 (https=)
JP (1) JP2008534672A (https=)
KR (1) KR20070108938A (https=)
AP (1) AP2007004172A0 (https=)
AR (1) AR053839A1 (https=)
AU (1) AU2006231919A1 (https=)
BR (1) BRPI0610533A2 (https=)
CA (1) CA2603899A1 (https=)
CR (1) CR9417A (https=)
DO (1) DOP2006000080A (https=)
GT (1) GT200600133A (https=)
IL (1) IL186119A0 (https=)
MX (1) MX2007012386A (https=)
NL (1) NL1031525C2 (https=)
NO (1) NO20075505L (https=)
PE (1) PE20061301A1 (https=)
TN (1) TNSN07373A1 (https=)
TW (1) TW200716101A (https=)
UY (1) UY29452A1 (https=)
WO (1) WO2006106427A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781642A1 (en) * 2004-08-06 2007-05-09 Pharmacia & Upjohn Company LLC Oxazolidinones containing oxindoles as antibacterial agents
KR100891485B1 (ko) 2007-10-29 2009-04-02 주식회사 만도 디스크 브레이크의 주차브레이크 장치
US20090124737A1 (en) * 2007-11-12 2009-05-14 Eastman Chemical Company Acrylic plastisol viscosity reducers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
JP2865211B2 (ja) 1988-09-15 1999-03-08 ファルマシア・アンド・アップジョン・カンパニー 5’―インドリニル―5β―アミドメチルオキサゾリジン―2―オン類、3―(縮合環置換)フェニル―5β―アミドメチルオキサゾリジン―2―オン類および3―(窒素原子置換)フェニル―5β―アミドメチルオキサゾリジン―2―オン類
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
DE19649095A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue Heteroaryl-Oxazolidinone
BR9907183A (pt) 1998-01-23 2003-06-10 Versicor Inc Colet neas combinatórias de oxazolidinona, composições e processos de preparação
DE69912264T2 (de) 1998-04-14 2004-07-22 Samsung Fine Chemicals Co., Ltd. Verfahren zur herstellung chiraler (s)-2,3-disubstituierter 1-propylamin-derivate
AU1379900A (en) 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel substituted phenyloxazolidone derivatives
HK1040707A1 (zh) 1998-11-27 2002-06-21 法玛西雅厄普约翰美国公司 具有硫代羰基官能團的噁唑烷酮抗菌劑
JP2003501351A (ja) 1999-05-27 2003-01-14 ファルマシア・アンド・アップジョン・カンパニー 抗菌剤としての二環系オキサゾリジノン
ES2256318T3 (es) 2000-10-17 2006-07-16 PHARMACIA & UPJOHN COMPANY LLC Metodos de produccion de compuestos de oxazolidinona.
DE60212959T2 (de) 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
AU2002255803B2 (en) 2001-04-20 2008-07-03 Pharmacia And Upjohn Company Process to prepare oxazolidinones
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
EP1781642A1 (en) * 2004-08-06 2007-05-09 Pharmacia & Upjohn Company LLC Oxazolidinones containing oxindoles as antibacterial agents

Also Published As

Publication number Publication date
CR9417A (es) 2007-12-04
JP2008534672A (ja) 2008-08-28
CA2603899A1 (en) 2006-10-12
MX2007012386A (es) 2007-11-07
GT200600133A (es) 2006-11-29
WO2006106427A8 (en) 2007-12-06
AR053839A1 (es) 2007-05-23
KR20070108938A (ko) 2007-11-13
US7435751B2 (en) 2008-10-14
NO20075505L (no) 2007-10-31
US20060229349A1 (en) 2006-10-12
NL1031525A1 (nl) 2006-10-09
AP2007004172A0 (en) 2007-10-31
AU2006231919A1 (en) 2006-10-12
NL1031525C2 (nl) 2007-01-30
UY29452A1 (es) 2006-11-30
EP1869030A1 (en) 2007-12-26
TNSN07373A1 (fr) 2009-03-17
DOP2006000080A (es) 2006-12-15
IL186119A0 (en) 2008-01-20
BRPI0610533A2 (pt) 2010-06-29
WO2006106427A1 (en) 2006-10-12
PE20061301A1 (es) 2007-02-09

Similar Documents

Publication Publication Date Title
TNSN08407A1 (en) Organic compounds
EA200702497A1 (ru) Замещенные арилпиразолы для применения против паразитов
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
EA200970140A1 (ru) Производные и аналоги n-этилхинолонов и n-этилазахинолонов
HRP20120323T1 (en) Diarylhydantoin compounds
MX2010004493A (es) Compuestos de tropano.
TW200640867A (en) Pyridine-3-carboxamide derivatives as CB1 inverse agonists
MY148703A (en) Polycyclic cinnamide derivatives
TW200612958A (en) Substituted imidazole derivatives
EA200801128A1 (ru) Пери-конденсированные трициклические соединения, полезные в качестве антибактериальных средств
MX2009005217A (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos.
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
GB0607954D0 (en) Organic compounds
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2008038092A3 (en) Substituted piperidinophenyl oxazolidinones
MY152557A (en) 3-aminocyclopentanecarboxamides as chemokine receptor modulators
TW200724539A (en) Benzimidazole derivative and use thereof
BRPI0609426B8 (pt) naftiridonas e quinolonas de alquilidenil-heterocíclicas de 7-amino
TW200716101A (en) 7-fluoro-1, 3-dihydro-indol-2-one oxazolidinones as antibacterial agents
TW200612924A (en) Oxazolidinones containing oxindoles as antibacterial agents
MY150776A (en) Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria
UA88701C2 (ru) Производные хинолина как антибактериальные агенты
TW200637855A (en) An oxindole oxazolidinone as antibacterial agent
SG166799A1 (en) Quinoline derivatives as antibacterial agents
DE602007008947D1 (en) 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3-modulatoren